Personal tools

MCL coexpression mm9:222

From FANTOM5_SSTAR

Revision as of 16:10, 10 October 2012 by Autoedit (talk | contribs) (Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0005634;nucleus;0.000579663125793403;22589,20658,109331,81702,21969,100710,11737,228005,94246!GO:0006259;DNA metabolic pro...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr10:107697886..107697901,+p@chr10:107697886..107697901
+
Mm9::chr11:117623812..117623827,+p@chr11:117623812..117623827
+
Mm9::chr11:75555748..75555764,+p@chr11:75555748..75555764
+
Mm9::chr11:94158437..94158452,-p7@Luc7l3
Mm9::chr11:94159097..94159133,-p4@Luc7l3
Mm9::chr11:94159135..94159150,-p8@Luc7l3
Mm9::chr11:94161291..94161382,-p5@Luc7l3
Mm9::chr11:94162886..94162899,-p@chr11:94162886..94162899
-
Mm9::chr11:94170962..94170981,-p@chr11:94170962..94170981
-
Mm9::chr12:60172455..60172477,+p@chr12:60172455..60172477
+
Mm9::chr12:60172575..60172590,+p@chr12:60172575..60172590
+
Mm9::chr12:84992240..84992272,+p@chr12:84992240..84992272
+
Mm9::chr12:85001540..85001595,+p@chr12:85001540..85001595
+
Mm9::chr12:85009144..85009225,-p@chr12:85009144..85009225
-
Mm9::chr13:14279165..14279179,+p@chr13:14279165..14279179
+
Mm9::chr14:75276101..75276106,-p@chr14:75276101..75276106
-
Mm9::chr14:75723653..75723658,+p@chr14:75723653..75723658
+
Mm9::chr14:75730228..75730246,+p@chr14:75730228..75730246
+
Mm9::chr16:91654866..91654920,+p3@Son
Mm9::chr17:32350640..32350672,-p@chr17:32350640..32350672
-
Mm9::chr18:32020264..32020279,+p@chr18:32020264..32020279
+
Mm9::chr19:53697535..53697548,+p@chr19:53697535..53697548
+
Mm9::chr19:55539264..55539277,+p@chr19:55539264..55539277
+
Mm9::chr2:160495855..160495908,+p6@Top1
Mm9::chr2:69587083..69587094,+p@chr2:69587083..69587094
+
Mm9::chr2:69587115..69587134,+p@chr2:69587115..69587134
+
Mm9::chr2:69587435..69587461,+p@chr2:69587435..69587461
+
Mm9::chr4:49662964..49662982,+p2@Rnf20
Mm9::chr4:58496493..58496514,-p1@ENSMUST00000119701
Mm9::chr5:151603420..151603434,+p@chr5:151603420..151603434
+
Mm9::chr5:42223804..42223826,-p@chr5:42223804..42223826
-
Mm9::chr5:90672804..90672850,-p@chr5:90672804..90672850
-
Mm9::chr5:90692406..90692420,-p5@Ankrd17
Mm9::chr8:125537100..125537114,-p@chr8:125537100..125537114
-
Mm9::chr9:20285349..20285363,-p@chr9:20285349..20285363
-
Mm9::chr9:62221442..62221455,+p8@Anp32a
Mm9::chr9:82794408..82794451,-p@chr9:82794408..82794451
-
Mm9::chrX:103070746..103070764,-p5@Atrx
Mm9::chrX:34640120..34640124,-p@chrX:34640120..34640124
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0005634nucleus0.000579663125793403
GO:0006259DNA metabolic process0.000579663125793403
GO:0005694chromosome0.00116694694797247
GO:0006261DNA-dependent DNA replication0.00897090187905303
GO:0043231intracellular membrane-bound organelle0.00917410638940051
GO:0043227membrane-bound organelle0.00917410638940051
GO:0043229intracellular organelle0.0171860332599524
GO:0043226organelle0.0171860332599524
GO:0003682chromatin binding0.0171860332599524
GO:0003676nucleic acid binding0.0171860332599524
GO:0043204perikaryon0.0185730418610017
GO:0003677DNA binding0.0185730418610017
GO:0006139nucleobase, nucleoside, nucleotide and nucleic acid metabolic process0.0198003208463124
GO:0003917DNA topoisomerase type I activity0.0200732190252243
GO:0006260DNA replication0.0200732190252243
GO:0003918DNA topoisomerase (ATP-hydrolyzing) activity0.0222346756453473
GO:0016853isomerase activity0.0226901522085912
GO:0040016embryonic cleavage0.0237111410404715
GO:0003916DNA topoisomerase activity0.0246049051280258
GO:0006281DNA repair0.0246049051280258
GO:0000785chromatin0.0246049051280258
GO:0006265DNA topological change0.0246049051280258
GO:0030983mismatched DNA binding0.0246049051280258
GO:0032392DNA geometric change0.0246049051280258
GO:0006268DNA unwinding during replication0.0246049051280258
GO:0032508DNA duplex unwinding0.0246049051280258
GO:0043232intracellular non-membrane-bound organelle0.026948408889325
GO:0043228non-membrane-bound organelle0.026948408889325
GO:0006298mismatch repair0.026948408889325
GO:0045005maintenance of fidelity during DNA-dependent DNA replication0.0279557744820937
GO:0006974response to DNA damage stimulus0.0279557744820937
GO:0051301cell division0.0279557744820937
GO:0044424intracellular part0.029801112072005
GO:0009719response to endogenous stimulus0.0299004299360272
GO:0016363nuclear matrix0.0304182013251265
GO:0005622intracellular0.0305396399708874
GO:0006325establishment and/or maintenance of chromatin architecture0.0305396399708874
GO:0043170macromolecule metabolic process0.0305396399708874
GO:0007492endoderm development0.0305396399708874
GO:0006323DNA packaging0.0305396399708874
GO:0043283biopolymer metabolic process0.0343721912992878
GO:0044427chromosomal part0.0343721912992878
GO:0003690double-stranded DNA binding0.0346113957404018
GO:0003725double-stranded RNA binding0.0418267428160646
GO:0051276chromosome organization and biogenesis0.0498164078999933



Relative expression of the co-expression cluster over median <br>Analyst:


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:222&oldid=2141958"